Search Results 391-400 of 17024 for pharmacogenetics

  1. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  2. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...

  3. Mayo Clinic Medical Edge Genetic Testing for Breast Cancer Intro

    Intro: It could be your mom, sister, aunt or best friend. One out of eight women will get breast cancer in her lifetime. A small subset of the women who get ...

  4. Mayo Clinic: 10 Ways the Human Genome Can Affect Diagnosis and Treatment in Health

    1. It's already influenced drug labels and uses for some medicines. The U.S. Food and Drug Administration has changed medication labeling, doses and uses ...

  5. A Study of Autoimmune Functions in Patients with Myocarditis - Mayo Clinic

    The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also cause autoimmune ...

  6. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  7. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  8. Focus areas - Department of Psychiatry and Psychology - Mayo Clinic Research

    Mayo Clinic Dept. of Psychiatry and Psychology research teams explore clinical disorders and how medical diseases interface with psychiatry and psychology.

  9. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  10. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...